TABLE OF CONTENTS
1. EXECUTIVE SUMMARY
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Model
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Value Chain Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis
6. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET, BY APPLICATION
6.1. Overview
6.2. Bone Graft Substitutes
6.3. Collagen-based Scaffolds
6.4. Hemostats
6.5. Skin Substitutes
6.6. Cartilage Repairs
6.7. Others
7. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET, BY REGION
7.1. Overview
7.1. North America
7.1.1. US
7.1.2. Canada
7.2. Europe
7.2.1. Germany
7.2.2. France
7.2.3. UK
7.2.4. Italy
7.2.5. Spain
7.2.6. Rest of Europe
7.3. Asia-Pacific
7.3.1. China
7.3.2. India
7.3.3. Japan
7.3.4. South Korea
7.3.5. Australia
7.3.6. Rest of Asia-Pacific
7.4. Rest of the World
7.4.1. Middle East
7.4.2. Africa
7.4.3. Latin America
8. COMPETITIVE LANDSCAPE
8.1. Overview
8.2. Competitive Analysis
8.3. Market Share Analysis
8.4. Major Growth Strategy in the Global Bovine-based Collagen for Biomedical Applications Market,
8.5. Competitive Benchmarking
8.6. Leading Players in Terms of Number of Developments in the Global Bovine-based Collagen for Biomedical Applications Market,
8.7. Key Developments and Growth Strategies
8.7.1. New Product Launch/Service Deployment
8.7.2. Merger & Acquisitions
8.7.3. Joint Ventures
8.8. Major Players Financial Matrix
8.8.1. Sales & Operating Income, 2023
8.8.2. Major Players R&D Expenditure. 2023
9. COMPANY PROFILES
9.1. Rousselot
9.1.1. Company Overview
9.1.2. Financial Overview
9.1.3. Products Offered
9.1.4. Key Developments
9.1.5. SWOT Analysis
9.1.6. Key Strategies
9.2. BBI Solution
9.2.1. Company Overview
9.2.2. Financial Overview
9.2.3. Products Offered
9.2.4. Key Developments
9.2.5. SWOT Analysis
9.2.6. Key Strategies
9.3. Foodmate Co. Ltd
9.3.1. Company Overview
9.3.2. Financial Overview
9.3.3. Products Offered
9.3.4. Key Developments
9.3.5. SWOT Analysis
9.3.6. Key Strategies
9.4. BOTISS BIOMATERIALS GMBH
9.4.1. Company Overview
9.4.2. Financial Overview
9.4.3. Products Offered
9.4.4. Key Developments
9.4.5. SWOT Analysis
9.4.6. Key Strategies
9.5. Medtronic PLC
9.5.1. Company Overview
9.5.2. Financial Overview
9.5.3. Products Offered
9.5.4. Key Developments
9.5.5. SWOT Analysis
9.5.6. Key Strategies
9.6. Kyeron
9.6.1. Company Overview
9.6.2. Financial Overview
9.6.3. Products Offered
9.6.4. Key Developments
9.6.5. SWOT Analysis
9.6.6. Key Strategies
9.7. Collagen Matrix Inc.
9.7.1. Company Overview
9.7.2. Financial Overview
9.7.3. Products Offered
9.7.4. Key Developments
9.7.5. SWOT Analysis
9.7.6. Key Strategies
9.8. COLLAGEN SOLUTIONS PLC
9.8.1. Company Overview
9.8.2. Financial Overview
9.8.3. Products Offered
9.8.4. Key Developments
9.8.5. SWOT Analysis
9.8.6. Key Strategies
9.9. Titan Biotech
9.9.1. Company Overview
9.9.2. Financial Overview
9.9.3. Products Offered
9.9.4. Key Developments
9.9.5. SWOT Analysis
9.9.6. Key Strategies
9.10. Symatese
9.10.1. Company Overview
9.10.2. Financial Overview
9.10.3. Products Offered
9.10.4. Key Developments
9.10.5. SWOT Analysis
9.10.6. Key Strategies
9.11. DCP Ingredients (DCP B.V.)
9.11.1. Company Overview
9.11.2. Financial Overview
9.11.3. Products Offered
9.11.4. Key Developments
9.11.5. SWOT Analysis
9.11.6. Key Strategies
9.12. LAPI GELATINE S.p.a
9.12.1. Company Overview
9.12.2. Financial Overview
9.12.3. Products Offered
9.12.4. Key Developments
9.12.5. SWOT Analysis
9.12.6. Key Strategies
10. APPENDIX
10.1. References
10.2. Related Reports
LIST OF TABLES
TABLE 1 GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET, SYNOPSIS, 2019-2032
TABLE 2 GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET, ESTIMATES & FORECAST, 2019-2032 (USD BILLION)
TABLE 3 GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 4 NORTH AMERICA: BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 5 US: BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 6 CANADA: BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 1 EUROPE: BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 2 GERMANY: BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 3 FRANCE: BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 4 ITALY: BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 5 SPAIN: BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 6 UK: BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 7 REST OF EUROPE: BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 8 ASIA-PACIFIC: BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 9 JAPAN: BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 10 CHINA: BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 11 INDIA: BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 12 AUSTRALIA: BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 13 SOUTH KOREA: BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 14 REST OF ASIA-PACIFIC: BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 15 REST OF THE WORLD: BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 16 MIDDLE EAST: BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 17 AFRICA: BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 18 LATIN AMERICA: BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET
FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET
FIGURE 4 GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET, SHARE (%), BY APPLICATION, 2023
FIGURE 5 GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET, SHARE (%), BY REGION, 2023
FIGURE 6 NORTH AMERICA: BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET, SHARE (%), BY REGION, 2023
FIGURE 7 EUROPE: BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET, SHARE (%), BY REGION, 2023
FIGURE 8 ASIA-PACIFIC: BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET, SHARE (%), BY REGION, 2023
FIGURE 9 REST OF THE WORLD: BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET, SHARE (%), BY REGION, 2023
FIGURE 10 GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET: COMPANY SHARE ANALYSIS, 2023 (%)
FIGURE 11 ROUSSELOT: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 12 ROUSSELOT: SWOT ANALYSIS
FIGURE 13 BBI SOLUTION: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 14 BBI SOLUTION: SWOT ANALYSIS
FIGURE 15 FOODMATE CO. LTD: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 16 FOODMATE CO. LTD: SWOT ANALYSIS
FIGURE 17 BOTISS BIOMATERIALS GMBH: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 18 BOTISS BIOMATERIALS GMBH: SWOT ANALYSIS
FIGURE 19 MEDTRONIC PLC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 20 MEDTRONIC PLC.: SWOT ANALYSIS
FIGURE 21 KYERON: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 22 KYERON: SWOT ANALYSIS
FIGURE 23 COLLAGEN MATRIX INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 24 COLLAGEN MATRIX INC.: SWOT ANALYSIS
FIGURE 25 COLLAGEN SOLUTIONS PLC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 26 COLLAGEN SOLUTIONS PLC: SWOT ANALYSIS
FIGURE 27 TITAN BIOTECH: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 28 TITAN BIOTECH: SWOT ANALYSIS
FIGURE 29 SYMATESE: FINANCIAL OVERVIEW SNAPSHOT
A. SYMATESE: SWOT ANALYSIS
FIGURE 30 DCP INGREDIENTS (DCP B.V.): FINANCIAL OVERVIEW SNAPSHOT
FIGURE 31 DCP INGREDIENTS (DCP B.V.): SWOT ANALYSIS
FIGURE 32 LAPI GELATINE S.P.A: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 33 LAPI GELATINE S.P.A: SWOT ANALYSIS